Incidence and predictors of opportunistic infections among HIV-infected adults under antiretroviral therapy, northern Ethiopia
DOI:
https://doi.org/10.71624/s04kqj71Article Metrics
Keywords:
Incidence, Predictors, Opportunistic infections, HIV-infected adults, Antiretroviral therapy, EthiopiaAbstract
Introduction: Opportunistic infections (OIs) remain a significant cause of morbidity and mortality among HIV-infected individuals, despite advancements in antiretroviral therapy (ART), especially in middle- and low-income countries. The incidence and predictors of these infections remain largely unknown. Therefore, this study aimed to investigate the incidence, median survival time, and predictors of OIs among HIV-infected adults receiving ART at Adigrat General Hospital in northern Ethiopia.
Methods: A hospital-based retrospective cohort study was conducted among 362 HIV- infected adults on ART, enrolled from September 1, 2013, to December 31, 2017. Data were extracted from medical records, and Kaplan-Meier analysis, log- rank test and Cox regression were used to determine the probability of survival, compare survival among categories of variables, and estimate the effect size of adjusted hazard ratios for opportunistic infections, respectively.
Results: A total of 106 (29.28%) were diagnosed with OIs, giving an overall incidence rate of 13.5 per 100 person-years. The median survival time to an OI event was 13 months. The independent predictors of OIs for this cohort were a baseline CD4 count <200 cells/mm³ (AHR=1.96, 95%CI; 1.27, 3.01), a current CD4 count <200 cells/mm³ (AHR=2.53, 95%CI; 1.39, 4.60), a baseline hemoglobin level <12.5 g/dl (AHR=2.6, 95%CI 1.49-4.53). Similarly, being in a state of poor/fair adherence (AHR=4.45, 95%CI 2.16-9.16), a baseline weight <50 kg (AHR=2.22, 95%CI 1.09-4.45), a functional status of ambulatory/bedridden (AHR=3.06, 95%CI 1.50-6.21), unemployment status (AHR=2.32, 95%CI 1.49-3.61), and working part-time (AHR=4.09, 95%CI 1.57-10.71) were significant predictors.
Conclusions: The overall incidence of OIs among HIV-infected patients in this region was high. Interventions targeting patients with low CD4 counts, anemia, and socioeconomic challenges are crucial to improve outcomes and reduce the burden of OIs.
References
1. HIV/AIDS, J.U.N.P.o., Global Report: UNAIDS report on the global AIDS epidemic/2012.[Internet].[cited 2017 May 28].
2. Kaplan, J.E., et al., Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR Recomm Rep, 2009. 58(4): p. 1-207.
3. Chaisson, R.E., et al., Impact of opportunistic disease on survival in patients with HIV infection. Aids, 1998. 12(1): p. 29-33.
4. HIV/AIDS, J.U.N.P.o., Fact sheet: World AIDS Day 2019—global HIV statistics. 2019.
5. EPHI, H., Related Estimates and Projections for Ethiopia–2017. Ethiopian Public Health Institute, 2017.
6. Organization, W.H., WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007: World Health Organization.
7. Organization, W.H., Patient monitoring guidelines for HIV care and antiretroviral therapy (ART). 2006.
8. Oh, M.-d., et al., Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea. Clinical infectious diseases, 1999. 29(6): p. 1524-1528.
9. Chaisson, R.E. and R.D. Moore, Prevention of opportunistic infections in the era of improved antiretroviral therapy. Journal of acquired immune deficiency syndromes and human retrovirology: official publication of the International Retrovirology Association, 1997. 16: p. S14-22.
10. Boulle, A., et al., Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS Med, 2014. 11(9): p. e1001718.
11. Ford, N., et al., Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. The lancet HIV, 2015. 2(10): p. e438-e444.
12. Coelho, L.E., et al., Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil. BMC Infectious Diseases, 2016. 16(1): p. 134.
13. Stine, G.J., AIDS Update, 2003: An Annual Overview of Acquired Immune Deficiency Syndrome. 2003: Benjamin-Cummings Publishing Company.
14. Damtie, D., et al., Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC research notes, 2013. 6(1): p. 534.
15. Ahmed, A., D. Mekonnen, and M. Kindie, Incidence and predictors of tuberculosis among adult people living with HIV/AIDS in Afar public health facilities, Northeast Ethiopia. Aids, 2015. 1: p. 3-10.
16. San-Andrés, F.-J., et al., Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989–1997. Clinical infectious diseases, 2003. 36(9): p. 1177-1185.
17. De Beaudrap, P., et al., Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort. BMC Infectious Diseases, 2010. 10(1): p. 179.
18. Tanuma, J., et al., Incidence of AIDS-defining opportunistic infections and mortality during antiretroviral therapy in a cohort of adult HIV-infected individuals in Hanoi, 2007-2014. PLoS One, 2016. 11(3): p. e0150781.
19. Mocroft, A., et al., Changes in AIDS-defining illnesses in a London Clinic, 1987-1998. Journal of acquired immune deficiency syndromes (1999), 1999. 21(5): p. 401-407.
20. Rojanawiwat, A., et al., Impact of the National Access to Antiretroviral Program on the incidence of opportunistic infections in Thailand. International Health, 2011. 3(2): p. 101-107.
21. Gadelha, A.J., et al., Morbidity and survival in advanced AIDS in Rio de Janeiro, Brazil. Revista do Instituto de Medicina Tropical de São Paulo, 2002. 44(4): p. 179-186.
22. Ghate, M., et al., Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. International journal of infectious diseases, 2009. 13(1): p. e1-e8.
23. Seyler, C., et al., Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis. AIDS research and human retroviruses, 2007. 23(11): p. 1338-1347.
24. Tariku, Y., et al., Incidence of opportunistic infections among adult HIV positive people receiving co-trimoxazole prophylaxis. Int. J. Public Health Sci, 2015. 4: p. 172-179.
25. Manosuthi, W., et al., Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. Journal of Infection, 2007. 55(5): p. 464-469.
26. Mitiku, H., F. Weldegebreal, and Z. Teklemariam, Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia. HIV/AIDS (Auckland, NZ), 2015. 7: p. 137.
27. Alene, K.A., A. Nega, and B.W. Taye, Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infectious Diseases, 2013. 13(1): p. 292.
28. Moges, N. and G. Kassa, Prevalence of opportunistic infections and associated factors among HIV positive patients taking anti-retroviral therapy in DebreMarkos Referral Hospital, Northwest Ethiopia. J AIDs Clin Res, 2014. 5(5): p. 1-300.
29. Iroezindu, M., et al., Prevalence and risk factors for opportunistic infections in HIV patients receiving antiretroviral therapy in a resource-limited setting in Nigeria. J AIDs Clin Res, 2013. 3: p. 002.
30. Chow, J.Y., et al., Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia. AIDS care, 2015. 27(7): p. 844-848.
31. Rubaihayo, J., et al., Prevalence and Factors Associated with Opportunistic Infections in HIV Positive Patients on Antiretroviral Therapy in Uganda. Int J Trop Dis Heal Buenos Aires Univ Argentina, 2015. 10(1): p. 1-13.
32. Bekele, H., et al., Incidence and predictors of tuberculosis among adult PLWHA at public health facilities of Hawassa City. International Journal of Public Health Science, 2017. 6(3): p. 266-274.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Haftamu Ebuy Teka, Berihu Gebreyohanis Hailu, Girmatsion Fisseha, Letekristos Gebregziabher, Shishay Wahdey (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This journal and its articles are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
